What are the short-term and long-term safety profiles of Semax?

Semax, a heptapeptide developed in Russia, has been studied for its neuroprotective properties and cognitive enhancement. In terms of short-term safety, Semax appears to be well-tolerated within recommended dosages, with minor side effects such as nasal irritation and headache [11]. Long-term safety data are less comprehensive, but the peptide’s neuroprotective and immunomodulatory effects suggest a positive impact on neuronal health and immune function [11]. However, further research is needed to fully understand its long-term safety profile.

What the AI assistants say

The AI assistants collectively agree that Semax has a favorable short-term safety profile. They note that it is generally well-tolerated with minor side effects such as nasal irritation, headache, and potential sleep disturbances [1]. One AI assistant points out that long-term safety data are incomplete and that there is no strong evidence proving chronic daily Semax is safe for various health parameters [3]. Another assistant highlights that most Semax protocols are short-term, and there is a lack of large, multicenter, Western RCTs and limited data beyond 90 days of continuous use [1]. The AI assistants collectively suggest that while short-term use seems safe, long-term effects remain not fully established.

What the research actually shows

Semax is a fragment of the adrenocorticotropic hormone (ACTH, ACTH4-10) with a molecular weight of 813.920 g/mol [11]. It has been studied for its neuroprotective properties and its ability to counteract the inhibition of learning and memory induced by heavy metals, neurotoxic effects, and neurodegeneration caused by dopamine oxidation [11].

  • Short-term Safety: The recommended dosage for Semax is between 750–1000 mcg intranasally and 100–300 mcg Sub Q daily [11]. Exceeding these maximum dosages can lead to desensitization, indicating that short-term use within the recommended dosages is considered to be safe [11].

  • Long-term Safety: Semax has been shown to promote the survival of neurons during hypoxia and glutamate neurotoxicity, increase the amount and mobility of immune cells, and enhance the expression of chemokine and immunoglobulin genes [11]. It also influences the expression of genes that promote the formation and functioning of the vascular system in studies on brain focal ischemia, contributing to mitochondrial stability under stress induced by the deregulation of calcium ion flow [11]. These properties suggest that Semax has a positive impact on neuronal health and immune function, which may contribute to a favorable long-term safety profile [11].

However, it is important to note that the long-term effects of any substance can only be conclusively determined through extensive clinical trials and ongoing monitoring [11]. While the current research on Semax indicates positive effects on neuronal survival, immune function, and vascular health, long-term studies are necessary to fully understand its safety profile, particularly at larger dosages or in specific groups [11].

Where AI consensus and the research diverge

The AI assistants collectively suggest that long-term safety data for Semax are incomplete and that there is a lack of evidence proving chronic daily Semax is safe for various health parameters [1][3]. This aligns with the research, which indicates that while Semax has shown promising neuroprotective and immunomodulatory effects, further research is needed to fully understand its long-term safety profile [11].

Bottom line: Semax’s short-term safety profile is favorable within recommended dosages, and its long-term safety appears promising due to neuroprotective and immunomodulatory effects, but further research is needed for complete understanding. [11]

References

  1. Handbook of Biologically Active Peptides
  2. Incretin-Based Therapies for Type 2 Diabetes
  3. Metabolic Syndrome_ Underlying Mechanisms and Drug Therapies
  4. Neuroprotective Effects of Tripeptides—Epigenetic Regulators — Khavinson, Vladimir (author)
  5. Peptide Protocols Volume One — William A Seeds MD
  6. Peptide Therapeutics_ Design and Development
  7. Peptide drug discovery and development _ Translational — edited by Miguel Castanho and
  8. Selenium_ Its Molecular Biology and Role in Human Health
  9. The Science of Longevity_ Unlocking the Secrets of Aging

Continue your research

Part of our Semax: Safety, Side Effects & Regulation guide.

Related topics:

PeptideXR is an open-access research project of Morpheus Institute of Technology — an AI + bioinformatics platform company advancing precision health.